LOW CHOLESTEROL INCREASES CANCER AND DEATH RISK

[Guest guest]

http://www.newswithviews.com:80/Richards/byron62.htm

 

 

 

By Byron J. Richards, CCN

 

August 28, 2008

NewsWithViews.com

 

In a major shot fired across the bow of the statin marketing machine, the levels

of LDL cholesterol that are the artificial targets of " health " promoted by the

American Heart Association (AHA) are now found to be associated with a

significant increased risk of cancer and death.

 

The AHA recommends an LDL level of 100 for prevention and 70 for high risk

patients. In the new study an LDL level of 107 was associated with a 33%

increased risk of cancer and death, an LDL level of 87 was associated with a 50%

increased risk. As the LDL goes lower the risk keeps getting worse. These

arbitrary AHA levels for LDL cholesterol were established by " experts " with

direct financial ties to the statin industry, who knew full well that reaching

their artificially low target levels for LDL would require double and triple

doses of statin drugs, thus dramatically increasing sales (which has indeed

happened).

 

The Vytorin fraud has pointed out quite clearly that lowering LDL cholesterol to

very low levels does not reduce cardiovascular disease. Another Vytorin study

also shows doing so increases cancer risk by 64%. The new study paints the clear

picture that lowering LDL too low actually increases the rate of death from any

cause. This new study also points out the statistical shenanigans that the

statin industry uses to hide the actual risks of these drugs in the studies that

have been published.

 

The data was so alarming that the researchers called for a statistical

reanalysis of the data from all existing cholesterol studies, using better

statistical models that actually reflect true risk. The results of this new

research led the authors to conclude " A low LDL cholesterol level is not

necessarily associated with optimal clinical outcomes but is a predictor of

cancer and death. "

 

We have known for many years that individuals who maintain an LDL cholesterol

level of 130 as they enter their 40s and 50s have much less heart disease as

they grow older. This is because they are healthy and have maintained fitness in

their cholesterol function and metabolism. There is no credible data to show

that lowering LDL numbers with statins actually produces a similar level of

health, especially to artificially low numbers. There is a huge difference

between having good cholesterol numbers because you are healthy and drugging

your body's synthesis of cholesterol with statins.

 

In the current study the ideal LDL cholesterol level was 126. The researchers

were able to identify a bell shaped curve, in terms of a departure in either

direction from this ideal number. LDL over 146 or less than 107 was associated

with 33% increased risk of cancer. LDL over 164 of less than 87 was associated

with a 50% increased risk. The risk keeps getting worse the higher or lower the

number progresses away from the ideal of 126. LDL in the range of 108 - 145 had

no statistically significant cancer risk, although being in the center of this

range is clearly best.

 

There have been a number of studies in the past that link low cholesterol and

cancer risk. However, these studies could not prove that the cancer was not

already there prior to the start of the study - which has been the main argument

used (besides statistical manipulation) by the statin industry to deny the

association. In the new study this issue was taken into account by eliminating

participants with less than 2.5 years follow up after the start of the study,

thus demonstrating that the results were not due to pre-existing cancer.

 

Needless to say, this study was not part of the marketing machine propaganda

that is rampant in universities and " scientific " journals that have been used to

promote the statin scam around the world, while actively blackmailing and

blacklisting any authors, institutions, or journals that dare to step on Big

Pharma's statin toes. This study was published on August 26, 2008 in the

Canadian Medical Association Journal. It was carried out in Hong Kong with

Chinese patients who had type II diabetes - the exact patient who is forced onto

aggressive cholesterol lowering with statin drugs in America.

 

It is quite clear that scientific knowledge and advanced statistical analysis

are no longer under the control of Big Pharma and its legions of scientists,

universities, and medical journals that are on the take, misrepresenting data,

and actively suppressing negative findings. The truth is coming out because Big

Pharma is targeting the citizens of the world as a new market for statin sales.

And they are also targeting our children, wanting infants seven months of age to

have LDL levels of 50 and keep them at that level their whole life (with drugs,

since such levels are totally abnormal).

 

The insanity must stop. Americans have been conned. Big Pharma and the American

Heart Association should be held responsible for past crimes and future intended

crimes against the health of our citizens under the false pretense of improved

cardiovascular health.

 

Link to full Canadian Medical Association Journal article.

 

© 2008 Truth in Wellness, LLC -

 

 

 

 

E-mail message checked by Internet Security (5.5.0.212)

Database version: 5.10570

http://www.pctools.com/uk/internet-security/